Uwe Rudolph completed his medical degree at the Freie Universitaet Berlin in 1987 and his dissertation in pharmacology at the same university in 1989. From 1989-1993 he was in the Department s of Cell Biology and Pharmacology at Baylor College of Medicine in Houston, TX, studying G protein-mediated signaling. From 1993-2005 he was at the Institute of Pharmacology and Toxicology of the University of Zurich, studying the physiological and pharmacological functions of GABA-A receptor subtypes. Since 2005 he is Director of the Laboratory of Genetic Neuropharmacology at McLean Hospital in Belmont, MA, and has an academic appointment at Harvard Medical School, Boston, MA. His research portfolio includes anesthetic pharmacology.
Biography Updated on 31 March 2010